It is considered a hormone-dependent disease characterized by molecular mechanisms involving activation of human epidermal growth factor receptor 2 (HER2), hormone receptors (estrogen receptor and progesterone receptor) and/or BRCA mutations [2]. The gene discussed is ERBB2; the disease is substance dependence.